GSK Hails Success For Novel Antibiotic – But Reaching $1bn Sales Will Be A Challenge

Company Expects To File In H1 2023

 
• By Andrew McConaghie
  
GSK scientists working in the lab
The novel antibiotic was discovered in GSK's labs, its development supported by funding from US government agency BARDA. • Source: GSK
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip